A Day Up For Ignyta, Inc.
Ignyta, Inc. (RXDX:NASDAQ) soared at $95.8, representing a gain of 165.7%. On Wed, Dec 07, 2022, RXDX:NASDAQ touched a New 2-Week High of $95.8. The stock appeared on our News Catalysts scanner on Wed, Dec 07, 2022 at 05:18 PM in the 'PUBLIC OFFERING' category. From Wed, Nov 23, 2022, the stock recorded 22.22% Up Days and 20.00% Green Days
About Ignyta, Inc. (RXDX:NASDAQ)
Ignyta Inc is a precision oncology biotechnology company. Its research is targeting tumor reduction and cancer treatment through both integrated therapeutic and companion diagnostics. It aims to develop and commercialize molecularly targeted therapies.
Top 10 Gainers:
- Ignyta, Inc. (RXDX:NASDAQ), 165.67%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 133.44%
- FLJ Group Limited (FLJ:NASDAQ), 57.3%
- Vor Biopharma Inc. (VOR:NASDAQ), 41.86%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 37.16%
- Summit Therapeutics plc (SMMT:NASDAQ), 33.33%
- NexGel Inc (NXGL:NASDAQ), 28.33%
- Eargo Inc. (EAR:NASDAQ), 27.48%
- Bit Brother Limited (BTB:NASDAQ), 23.65%
- MongoDB, Inc. (MDB:NASDAQ), 23.23%